Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026
Key Takeaways
- Bioidentical hormones are chemically identical to the hormones your body produces and can treat confirmed hormone deficiencies in men.
- Accurate diagnosis requires two separate morning fasting testosterone tests, plus symptoms, before starting treatment.
- FDA-approved testosterone products undergo strict safety testing and quality control, while compounded versions lack this level of oversight and may vary in dose.
- Testosterone therapy can raise red blood cells, affect the cardiovascular system, and suppress fertility, so ongoing medical monitoring is essential.
- Start your journey with a comprehensive evaluation at Mirror Plastic Surgery to explore safe, physician-led hormone therapy.
These points form the foundation of safe hormone therapy, and each is explored in detail below.
Why Men Are Researching Bioidentical Hormones
U.S. testosterone prescriptions rose from approximately 7.3 million in 2019 to over 11 million in 2024, according to IQVIA data. Many men now encounter competing marketing claims about “bioidentical” and “synthetic” hormones, feel uncertain about safety, and struggle to find clear, unbiased guidance.
This guide explains what bioidentical hormones are, how to recognize symptoms of deficiency, how FDA-approved and compounded products differ, which treatment options exist, what risks are documented, and how to choose a qualified physician. The focus stays on evidence and safety, not on promoting any single product or protocol.
Schedule a consultation at Mirror Plastic Surgery to begin a thorough, physician-led evaluation.
What Are Bioidentical Hormones?
Bioidentical hormones are molecularly identical to the hormones the human body produces naturally, including testosterone, estrogen, and progesterone. For men, the primary bioidentical hormone is testosterone (C₁₉H₂₈O₂). It is typically derived from diosgenin, which is extracted from wild yam or soy, then processed in a laboratory to match the human molecular structure exactly.
All FDA-approved testosterone products, including AndroGel, Testopel, and Depo-Testosterone, are bioidentical by molecular definition. The marketing term “bioidentical” is often used only for compounded preparations, which can create confusion. The true difference between FDA-approved and compounded products lies in regulation and manufacturing, not in molecular structure.
Symptoms of Low Testosterone in Men
Low testosterone in men can present with the following symptoms:
- Decreased libido and sexual desire
- Erectile dysfunction
- Persistent fatigue and low energy
- Loss of muscle mass and strength
- Increased body fat, particularly abdominal (belly) fat
- Mood changes including irritability and depression
- Reduced bone density
- Cognitive fog and poor concentration
These symptoms can also arise from obesity, thyroid disorders, sleep apnea, diabetes, and medication side effects. The Endocrine Society stresses that symptoms alone do not confirm low testosterone, so proper testing is essential before starting treatment. That is why the next step is understanding how to get tested correctly.
How to Get Tested for Low Testosterone
Accurate diagnosis follows a structured protocol. The EAU guidelines recommend measuring serum testosterone in the morning between 07:00 and 10:00 in the fasting state, noting that non-fasting measurements can underestimate total testosterone by more than 30%.
Key diagnostic steps include:
- Two separate low morning tests: The Endocrine Society requires at least two early-morning, fasting testosterone tests for diagnosis, since a single reading is not reliable.
- Diagnostic threshold: The American Urological Association defines male hypogonadism as total testosterone consistently below 300 ng/dL with signs or symptoms, confirmed on two separate morning blood draws. The Endocrine Society uses a harmonized lower limit near 264 ng/dL based on CDC-certified assays.
- Additional markers: LH and FSH distinguish primary from secondary hypogonadism, and a complete panel often includes estradiol, SHBG, prolactin, PSA in men over 40, and a complete blood count.
A 2026 NHANES analysis in the American Journal of Men’s Health found that 25.7% of U.S. men aged 18 and older have testosterone deficiency, defined as total testosterone below 300 ng/dL. Yet only 12% of men receiving initial testosterone prescriptions met strict guideline-based criteria for treatment, which highlights how crucial proper diagnosis is.
FDA-Approved vs. Compounded Bioidentical Hormones: Key Safety Differences
The choice between FDA-approved and compounded hormones shapes safety, consistency, and how well the treatment is studied. The table below summarizes how these options differ in regulatory oversight, manufacturing standards, dose consistency, and strength of the evidence base.
| Feature | FDA-Approved Testosterone | Compounded Bioidentical Hormones |
|---|---|---|
| Regulatory oversight | FDA-reviewed safety and efficacy data | Not FDA-approved or evaluated |
| Manufacturing standards | Good Manufacturing Practice (GMP) | Variable 503A/503B pharmacy standards |
| Dose consistency | Standardized, well-characterized pharmacokinetics | Documented inconsistency concerns (NASEM 2020) |
| Evidence base | Phase III trials, TRAVERSE, TTrials | Insufficient comparative effectiveness data |
In June 2026, after reviewing new data including the TRAVERSE trial, the FDA requested updates to testosterone prescribing information and removed language stating that safety and efficacy in age-related hypogonadism had not been established. This change reflects a regulatory shift that favors approved products with well-defined safety profiles.
Treatment Options for Bioidentical Testosterone Therapy
FDA-approved testosterone comes in several delivery formats, and the right choice depends on your lifestyle, side-effect profile, and goals. Here is how the main options compare.
- Intramuscular Injections (testosterone cypionate or enanthate): Typically administered weekly or bi-weekly. They are effective but can cause peaks and troughs in hormone levels, which may raise hematocrit more than other methods.
- Topical Gels (for example, AndroGel, Testim): Applied daily to the skin for steady absorption. Main limitations include the risk of transfer to others and variable absorption between patients.
- Transdermal Patches (Androderm): Provide consistent delivery with no transfer risk when placed correctly. Androderm patches can cause skin irritation in up to 60% of users.
- Subcutaneous Pellets (Testopel): Implanted under the skin every 3–6 months for long-lasting, stable levels with no daily maintenance. A controlled clinical study reported pellet extrusion in about 12% of procedures. Pellets cannot be removed once inserted.
- Oral Capsules (Jatenzo) and Nasal Gel (Natesto): Jatenzo requires twice-daily dosing with a fat-containing meal and carries a boxed warning for blood pressure elevation. Natesto nasal gel may have less impact on spermatogenesis than systemic formulations.
A qualified physician will match the formulation to your labs, lifestyle, medical history, and goals, rather than using a one-size-fits-all protocol.
Discuss your options with Dr. Chandawarkar to determine which FDA-approved testosterone formulation may fit your situation.
Risks and Side Effects of Testosterone Therapy
- Erythrocytosis (Elevated Red Blood Cells): The TRAVERSE trial reported hematocrit above 54% more often in the testosterone group than in the placebo group. This is the most common adverse effect of testosterone therapy and is usually managed with dose adjustments, a change in formulation, or therapeutic phlebotomy.
- Cardiovascular Considerations: The TRAVERSE trial (NEJM 2023, N=5,246) found no increase in major adverse cardiovascular events, with a hazard ratio of 0.96 (95% CI, 0.78–1.17). However, testosterone-treated men had higher rates of pulmonary embolism, atrial fibrillation, and acute kidney injury. Principal investigator Dr. Shalender Bhasin noted that these findings require careful consideration when making treatment decisions.
- Prostate Health: Harvard urologist Dr. Abraham Morgentaler explains that older beliefs about testosterone fueling prostate cancer have shifted, yet active prostate cancer remains a clear contraindication. PSA monitoring is required at baseline and throughout therapy.
- Fertility Suppression: Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, lowers intratesticular testosterone, and impairs spermatogenesis. Recovery after stopping treatment often takes 6 to 12 months and may be incomplete. Men who want future fertility should discuss alternatives such as clomiphene citrate or hCG.
- Other Effects: Acne, oily skin, fluid retention, worsening sleep apnea, and testicular atrophy can also occur. Because these side effects may appear gradually, physicians typically monitor patients at 3, 6, and 12 months, then annually, to detect and manage problems early.
Estrogen in Men: What You Need to Know
Men naturally produce estrogen through aromatization, which is the conversion of testosterone to estradiol by the aromatase enzyme. This process is normal, and estradiol supports bone health, blood vessel function, and libido in men.
When testosterone therapy raises total testosterone, estradiol levels can also increase, especially in men with higher body fat, because aromatase activity is greater in adipose tissue. Elevated estradiol may cause water retention, gynecomastia, and increased visceral fat. A dose-ranging study by Finkelstein et al. (NEJM 2013) showed that estrogen deficiency drives fat gain in men, while excess estrogen can also promote fat storage.
With careful dosing and monitoring, clinically significant estrogen elevation is uncommon. Physicians may adjust testosterone dose or injection frequency, or use aromatase inhibitors when estradiol remains above the optimal range with symptoms. Experts advise against routine, preventive use of aromatase inhibitors, since estradiol supports bone and vascular health in men. Most clinicians reserve these medications for persistent symptomatic hyperestrogenemia despite optimized dosing and lifestyle changes.
How Long Does It Take for HRT to Reduce Belly Fat?
A meta-analysis in the European Journal of Endocrinology (Saad et al., 2011) mapped the timeline of testosterone benefits. Sexual interest often improves within 3 to 6 weeks and plateaus around 6 months.1 Changes in fat mass, lean body mass, and muscle strength usually appear at 12 to 16 weeks and stabilize between 6 and 12 months.1
Testosterone therapy improves body composition rather than acting as a classic weight-loss drug. EAU guidelines report reductions in fat mass and increases in lean mass, with limited change in overall body weight. For men whose low testosterone is linked to excess weight and no other cause, the Endocrine Society recommends weight loss as first-line therapy before starting testosterone.
How To Choose a Provider for Bioidentical Hormone Therapy
Choosing the right physician is as important as choosing the right medication. Look for the following:
- Board-certified physician with relevant specialty training
- Comprehensive lab testing before prescribing, not treatment based on symptoms alone
- Personalized treatment plans tailored to labs, medical history, and goals
- Ongoing monitoring and follow-up at 3, 6, and 12 months, then annually
- Clear discussion of both FDA-approved and compounded options
Concerning signs include clinics that prescribe without blood tests, practices that rely only on compounded hormones without mentioning FDA-approved alternatives, and direct-to-consumer clinics that treat men with normal testosterone levels. A 2022 JAMA Internal Medicine study found that most direct-to-consumer testosterone clinics were willing to prescribe testosterone even when the patient’s levels were normal.
Dr. Akash Chandawarkar at Mirror Plastic Surgery is a Harvard-educated, Johns Hopkins-trained plastic surgeon with fellowship training in aesthetic surgery and medical innovation training at Stanford University. He offers 30–60 minute consultations, comprehensive lab analysis, and 24/7 concierge access. All hormone protocols are medically supervised, sourced from reputable providers with batch testing, and individualized to each patient’s labs and physiology. He also advises patients when treatment is unnecessary, placing long-term health ahead of short-term revenue.
Arrange a comprehensive evaluation with Dr. Chandawarkar at Mirror Plastic Surgery in St. Petersburg, Florida.
Common Misconceptions About Bioidentical Hormones
Bioidentical hormones are natural and risk-free. In reality, bioidentical hormones are potent medications with real side effects and documented risks. Insulin and thyroid hormone are also naturally occurring, yet both require careful medical management.
All bioidentical hormones work the same way. FDA-approved and compounded bioidentical hormones differ in regulation, quality control, dose consistency, and safety data. The molecules may match, but the oversight and evidence base do not.
Testosterone therapy always causes prostate cancer. The Endocrine Society’s 2018 guideline reports no conclusive evidence that TRT increases the risk of developing new prostate cancer, although it can stimulate existing prostate tissue. Regular PSA monitoring remains essential.
Bioidentical hormones are only for women. Men also use bioidentical hormones, primarily testosterone, when they have a clinically confirmed deficiency. The term “bioidentical” applies equally to FDA-approved testosterone products used in men.
Compounded hormones are more “natural” than FDA-approved options. Both types are synthesized in laboratories, and FDA-approved testosterone is molecularly identical to endogenous testosterone. The meaningful difference lies in regulatory oversight and quality standards.
Frequently Asked Questions
What Are the Negatives of Bioidentical Hormones?
Bioidentical hormones carry risks that require medical supervision. For men on testosterone therapy, erythrocytosis, or elevated red blood cell count, is the most common adverse effect and can increase blood viscosity and clotting risk. As noted earlier, the TRAVERSE trial documented a higher rate of erythrocytosis in testosterone-treated men. Additional risks include pulmonary embolism, atrial fibrillation, acute kidney injury, prostate tissue stimulation that requires PSA monitoring, fertility suppression, acne, fluid retention, and worsening sleep apnea. Compounded bioidentical hormones add concerns about inconsistent dosing and limited quality control, as described in the 2020 NASEM report. Physicians can usually manage these risks with appropriate dosing, careful selection of formulation, and regular follow-up.
Does Estrogen Increase Belly Fat in Men?
Estrogen can contribute to belly fat in some men. Estradiol forms through aromatization of testosterone, a process that is more active in men with higher body fat. Elevated estradiol can promote visceral fat accumulation. Research by Finkelstein et al. showed that estrogen deficiency drives fat gain in men, while excess estrogen can also support fat storage, especially in the abdominal region. With proper monitoring and dose management, significant estrogen elevation is uncommon during supervised testosterone therapy. Addressing obesity, which increases aromatase activity, often provides the most effective first step.
How Long Does It Take for HRT to Reduce Belly Fat?
Body composition changes from testosterone therapy usually appear after 12 to 16 weeks and stabilize between 6 and 12 months, according to a meta-analysis in the European Journal of Endocrinology.1 Reductions in body fat can take up to six months to notice.1 Testosterone mainly improves body composition by lowering fat mass and increasing lean mass, and it has limited impact on total body weight. Combining testosterone therapy with nutrition changes, exercise, and weight-loss therapies produces better results than hormones alone. Men with obesity-related low testosterone are generally advised to pursue weight loss as the first-line approach.
What Is the Difference Between FDA-Approved and Compounded Bioidentical Hormones?
FDA-approved testosterone products have completed rigorous Phase III clinical trials, follow Good Manufacturing Practice standards, show predictable pharmacokinetics, and carry FDA-approved labels with defined risks and monitoring guidance. Compounded bioidentical hormones are mixed by 503A or 503B pharmacies without FDA premarket review. They lack large-scale safety and efficacy data and may show dose variability. The 2020 NASEM report concluded that evidence does not show compounded bioidentical hormone therapy to be safer or more effective than FDA-approved options and raised concerns about dose variability and inconsistent sterility checks. The Endocrine Society, NAMS, and ACOG recommend FDA-approved formulations whenever they are available.
Are Bioidentical Hormones Safe for Men?
When prescribed for clinically diagnosed hypogonadism and closely supervised, FDA-approved testosterone therapy offers a favorable risk-benefit profile for many men. The TRAVERSE trial found no increase in major adverse cardiovascular events over a mean follow-up of 33 months. Specific risks, including pulmonary embolism, atrial fibrillation, and erythrocytosis, require careful patient selection, baseline evaluation, and ongoing monitoring. Safety depends on confirming the diagnosis with two low morning testosterone tests, using doses that target mid-normal physiologic levels, and maintaining regular follow-up. The “bioidentical” label alone does not guarantee safety; the regulatory framework and physician oversight surrounding the medication matter most.
Conclusion: Your Path to Safe, Effective Hormone Therapy
Bioidentical hormones can significantly improve quality of life for men with confirmed low testosterone when diagnosis is accurate, the formulation is appropriate, and treatment is medically supervised. The FDA-approved versus compounded distinction has major implications for safety and consistency. Proper testing requires two fasting morning blood draws and a comprehensive hormonal panel. Known risks become manageable when an experienced physician provides structured monitoring. Your provider should rely on evidence-based medicine rather than marketing language.
Each man’s situation is unique. Effective treatment reflects your labs, symptoms, medical history, and goals instead of a high-volume, standardized protocol. If you are experiencing symptoms of low testosterone and want to explore your options with a physician who prioritizes long-term health, Mirror Plastic Surgery offers detailed evaluation, personalized protocols, and ongoing concierge support.
Schedule your consultation at Mirror Plastic Surgery to begin your journey toward safe, evidence-based hormone care with Dr. Akash Chandawarkar.
Disclaimer: This article is for educational purposes and does not replace professional medical advice. Consult a qualified physician to determine whether bioidentical hormone therapy is appropriate for you.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
